Zobrazeno 1 - 10
of 541
pro vyhledávání: '"E, Gremese"'
Autor:
E. Lubrano, A. Armuzzi, S. Scriffignano, C. Felice, F.M. Perrotta, V. Venerito, S. Del Vescovo, R. Ramonda, G. Cassone, F. Atzeni, R. Caporali, F. Conti, E. Gremese, F. Iannone, M. Sebastiani, E.G. Favalli
Publikováno v:
Reumatismo (2024)
Objective. To provide a comprehensive overview of peripheral spondyloarthritis (pSpA), focusing specifically on its occurrence and management in patients with inflammatory bowel disease (IBD). Methods. An exhaustive literature search was conducted
Externí odkaz:
https://doaj.org/article/5a985579496e4e96a65205c4037ac51e
Publikováno v:
Reumatismo, Vol 76, Iss 3 (2024)
Objective. This paper aims to provide an overview of the use of treatments available for axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) during pregnancy and breastfeeding, according to current national recommendations and international
Externí odkaz:
https://doaj.org/article/c1081ea75d4b49a09233f218ac5bb08c
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis
Autor:
C. Caruso, L. Laterza, C. R. Settanni, S. Colantuono, C. Di Mario, B. Tolusso, F. Castrì, E. Gremese, F. Scaldaferri, A. Armuzzi, C. De Simone, K. Peris, A. Chiricozzi, A. Gasbarrini
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
We described a case of IPEX syndrome successfully controlled with dupilumab, an anti-IL4 receptor alpha subunit inhibitor. IPEX syndrome is a rare and generally fatal genetic disorder characterized by immune dysregulation, polyendocrinopathy and ente
Externí odkaz:
https://doaj.org/article/96e741e104df4a0583ef8abba24751dc
Autor:
B Tolusso, E Gremese, S Alivernini, C Di Mario, V Varriano, L Petricca, AM Paglionico, MR Gigante
Publikováno v:
Lupus Science and Medicine, Vol 9, Iss Suppl 2 (2022)
Externí odkaz:
https://doaj.org/article/3f34d38ad536446e8ee9eb9d80003df4
Autor:
C. Caruso, S. Colantuono, D. Pugliese, C. Di Mario, B. Tolusso, E. Gremese, G. Papparella, F. Castrì, A. Gasbarrini, A. Romano, A. Armuzzi
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 16, Iss 1, Pp 1-5 (2020)
Abstract Background Mepolizumab (MEP) is the first anti Interleukin (IL)-5 add-on therapy approved for the treatment of severe refractory eosinophilic asthma. Case presentation We describe here the case of a 49 years-old woman with Aspirin-exacerbate
Externí odkaz:
https://doaj.org/article/61a57094ea0d4007b5d8a9285db72428
Autor:
A. Manfredi, G. Cassone, S. Cerri, V. Venerito, A. L. Fedele, M. Trevisani, F. Furini, O. Addimanda, F. Pancaldi, G. Della Casa, R. D’Amico, R. Vicini, G. Sandri, P. Torricelli, I. Celentano, A. Bortoluzzi, N. Malavolta, R. Meliconi, F. Iannone, E. Gremese, F. Luppi, C. Salvarani, M. Sebastiani, on behalf of GISEA (Gruppo Italiano Studio Early Arthritis)
Publikováno v:
BMC Pulmonary Medicine, Vol 19, Iss 1, Pp 1-6 (2019)
Abstract Background Interstitial lung disease (ILD) is a severe systemic manifestation of rheumatoid arthritis (RA). High-resolution computed tomography (HRCT) represents the gold standard for the diagnosis of ILD, but its routine use for screening p
Externí odkaz:
https://doaj.org/article/911ae9207b9d4eeca950613e2567d296
Autor:
S.L. Bosello, M.S. Chimenti, P. Conigliaro, C. Iannuccelli, E. Gremese, F.R. Spinelli, M. Vadacca
Publikováno v:
Reumatismo, Vol 71, Iss 4 (2020)
Not available
Externí odkaz:
https://doaj.org/article/10808b00ab8740b79759a4fcd0ee8241
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
C Di Mario, V Varriano, L Petricca, AM Paglionico, MR Gigante, S Alivernini, B Tolusso, E Gremese
Publikováno v:
Friday 07 October 2022 from 13:00 to 14:10.
Publikováno v:
Friday 07 October 2022 from 09:50 to 11:20.